scout
|Videos|September 18, 2017

How the Results of COMBI-AD and CheckMate-238 Will Impact Melanoma Care

Michael A. Postow, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses how the results of the COMBI-AD study and the CheckMate-238 study will impact the care of patients with melanoma.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME